
Analysis of Cosmetic Efficacy Peptide Ingredients (Part 5): Carnosine
2026-04-03
In the field of efficacy skincare, oxidation and glycation are two fundamental drivers of skin aging. Oxidative damage disrupts cellular structures and collagen fibers, while glycation cross-links collagen, causing it to lose elasticity and leading to dull, ...
View More

Peptide-Drug Conjugates (PDCs): A New Hope in Targeted Cancer Therapy
2026-04-02
Cancer remains one of the leading causes of death worldwide, projected to claim 10 million lives by 2030. Current standard therapies, predominantly chemotherapy, lack tumor specificity and often cause severe off-target toxicities, limiting clinical efficacy ...
View More

Analysis of Cosmetic Efficacy Peptide Ingredients Series (Part 4): Nonapeptide-1
2026-04-02
In the first three parts of this series, we analyzed representative peptides: palmitoyl pentapeptide-4 for collagen remodeling, acetyl hexapeptide-8 for neuromodulation, and copper tripeptide for repair and fortification. This installment focuses on the depi...
View More

Research Progress on the Application Prospects of Self-Assembly of Cyclopeptide-Dendrimer Hybrid Molecules
2026-04-02
Self-assembly is one of the core research directions in the field of supramolecular chemistry. Relying on non-covalent intermolecular interactions (hydrophobic interactions, hydrogen bonds, π-π stacking, etc.), molecules spontaneously form ordered nano...
View More

Research Progress of Peptide-based Weight Loss Drugs
2026-04-01
Obesity has become a major global public health issue. It not only significantly increases the risk of metabolic diseases such as type 2 diabetes, cardiovascular diseases, and fatty liver disease but also imposes a heavy burden on public health care. Therefo...
View More

Challenges Faced by Peptide Drugs
2026-03-31
While peptide drugs are ushering in broad development opportunities driven by technological innovation and market demand, they also face multiple challenges in the process of industrialization, market competition, and global layout. These challenges involve ...
View More

Development Opportunities of Peptide Drugs
2026-03-30
As a cutting-edge track in biomedicine following small-molecule drugs and antibody drugs, peptide drugs combine the easy synthesis of small-molecule drugs with the high specificity of biopharmaceuticals. They perform prominently in terms of target accuracy a...
View More

Introduction to Foot-and-Mouth Disease Synthetic Peptide Vaccine
2026-03-30
Foot-and-mouth disease (FMD) synthetic peptide vaccine is a new type of veterinary vaccine developed based on peptide technology, primarily used to prevent and control foot-and-mouth disease virus (FMDV) infection. FMDV is a highly contagious virus that main...
View More

Pain-Modulating Peptides: Mechanisms of Action and Advances in Analgesic Drug Development
2026-03-27
Chronic pain has become a global public health challenge, with a population prevalence of 7% to 24%. Current mainstream analgesics, such as opioids and anticonvulsants, are limited by significant drawbacks like addiction and multi-system adverse effects, cre...
View More


